TMC Life Sciences Bhd.(MY:0101)
RM0.420.00 (0.00%)
MY:0101
TMC Life Sciences Bhd. financials statements
RM0.42
At close:0.00 (0.00%)
TMC Life Sciences Bhd. (0101) Ratios
TMC Life Sciences Bhd. Ratios
MY:0101's free cash flow for Q4 2025 was RM5.70M. For the 2025 fiscal year, MY:0101's free cash flow was decreased by RM-2.97M and operating cash flow was RM8.68M. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.69 | 1.84 | 2.55 | 2.66 | 2.27 |
| Quick Ratio | 1.51 | 1.69 | 2.42 | 2.54 | 2.15 |
| Cash Ratio | 0.83 | 0.96 | 1.65 | 1.13 | 1.54 |
| Solvency Ratio | 0.22 | 0.14 | 0.21 | 0.23 | 0.19 |
| Operating Cash Flow Ratio | 0.52 | 0.20 | 0.55 | 0.81 | 0.40 |
| Short-Term Operating Cash Flow Coverage | 1.29 | 0.60 | 3.61 | 3.55 | 4.72 |
| Net Current Asset Value | RM -50.56M | RM -76.67M | RM -63.04M | RM -39.15M | RM -100.92M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.16 | 0.19 | 0.17 | 0.19 |
| Debt-to-Equity Ratio | 0.17 | 0.21 | 0.25 | 0.23 | 0.25 |
| Debt-to-Capital Ratio | 0.14 | 0.18 | 0.20 | 0.19 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.10 | 0.14 | 0.19 | 0.17 | 0.19 |
| Financial Leverage Ratio | 1.29 | 1.33 | 1.37 | 1.34 | 1.37 |
| Debt Service Coverage Ratio | 1.04 | 1.00 | 3.05 | 2.40 | 6.12 |
| Interest Coverage Ratio | 3.68 | 0.82 | 5.25 | 5.38 | 16.13 |
| Debt to Market Cap | 0.18 | 0.24 | 0.20 | 0.18 | 0.23 |
| Interest Debt Per Share | 0.09 | 0.11 | 0.13 | 0.12 | 0.12 |
| Net Debt to EBITDA | 0.75 | 1.53 | 0.74 | 1.03 | 1.43 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.24% | 65.84% | 71.07% | 32.30% | 68.91% |
| EBIT Margin | 7.02% | 4.75% | 16.15% | 18.15% | 14.06% |
| EBITDA Margin | 16.52% | 14.62% | 24.50% | 26.20% | 20.56% |
| Operating Profit Margin | 7.02% | 2.21% | 15.86% | 15.93% | 13.91% |
| Pretax Profit Margin | 6.55% | 2.05% | 13.13% | 15.19% | 13.20% |
| Net Profit Margin | 4.42% | 1.04% | 12.60% | 11.73% | 16.98% |
| Continuous Operations Profit Margin | 4.42% | 1.04% | 12.60% | 11.73% | 16.98% |
| Net Income Per EBT | 67.53% | 50.99% | 96.01% | 77.25% | 128.62% |
| EBT Per EBIT | 93.23% | 92.57% | 82.80% | 95.33% | 94.88% |
| Return on Assets (ROA) | 1.56% | 0.32% | 3.34% | 3.42% | 3.65% |
| Return on Equity (ROE) | 2.00% | 0.42% | 4.55% | 4.58% | 5.00% |
| Return on Capital Employed (ROCE) | 2.77% | 0.75% | 4.58% | 5.06% | 3.25% |
| Return on Invested Capital (ROIC) | 1.78% | 0.37% | 4.33% | 3.82% | 3.22% |
| Return on Tangible Assets | 1.89% | 0.39% | 4.04% | 4.13% | 4.41% |
| Earnings Yield | 2.22% | 0.48% | 3.76% | 3.54% | 4.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.29 | 5.74 | 4.47 | 7.54 | 4.83 |
| Payables Turnover | 11.87 | 4.39 | 4.53 | 12.71 | 2.96 |
| Inventory Turnover | 14.30 | 7.42 | 6.74 | 20.18 | 6.97 |
| Fixed Asset Turnover | 0.55 | 0.48 | 0.44 | 0.48 | 0.33 |
| Asset Turnover | 0.35 | 0.31 | 0.26 | 0.29 | 0.22 |
| Working Capital Turnover Ratio | 4.56 | 2.70 | 2.33 | 2.18 | 2.17 |
| Cash Conversion Cycle | 52.76 | 29.65 | 55.27 | 37.78 | 4.84 |
| Days of Sales Outstanding | 57.98 | 63.57 | 81.70 | 48.41 | 75.58 |
| Days of Inventory Outstanding | 25.52 | 49.20 | 54.17 | 18.09 | 52.39 |
| Days of Payables Outstanding | 30.75 | 83.12 | 80.60 | 28.71 | 123.13 |
| Operating Cycle | 83.51 | 112.76 | 135.87 | 66.50 | 127.97 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.03 | 0.01 | 0.03 | 0.05 | 0.02 |
| Free Cash Flow Per Share | 0.03 | -0.01 | 0.01 | 0.03 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 3.57 | 0.28 | 1.39 | 1.86 | 0.49 |
| Capital Expenditure Coverage Ratio | 4.41 | 0.55 | 1.58 | 2.81 | 0.52 |
| Operating Cash Flow Coverage Ratio | 0.42 | 0.12 | 0.25 | 0.39 | 0.17 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.07 | 0.18 | 0.23 | 0.15 |
| Free Cash Flow Yield | 5.97% | -2.49% | 1.92% | 4.50% | -3.69% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 45.00 | 204.76 | 26.67 | 28.33 | 21.43 |
| Price-to-Sales (P/S) Ratio | 1.99 | 2.17 | 3.36 | 3.32 | 3.64 |
| Price-to-Book (P/B) Ratio | 0.90 | 0.88 | 1.21 | 1.29 | 1.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.74 | -40.20 | 51.96 | 22.24 | -27.07 |
| Price-to-Operating Cash Flow Ratio | 12.95 | 33.28 | 19.15 | 14.33 | 24.76 |
| Price-to-Earnings Growth (PEG) Ratio | 0.12 | -2.25 | -4.88 | 7.97 | 0.20 |
| Enterprise Value Multiple | 12.82 | 16.36 | 14.44 | 13.70 | 19.15 |
| Enterprise Value | 832.34M | 826.52M | 1.10B | 1.24B | 959.94M |
| EV to EBITDA | 12.82 | 16.36 | 14.44 | 13.70 | 19.15 |
| EV to Sales | 2.12 | 2.39 | 3.54 | 3.59 | 3.94 |
| EV to Free Cash Flow | 17.78 | -44.36 | 54.78 | 24.05 | -29.25 |
| EV to Operating Cash Flow | 13.75 | 36.72 | 20.19 | 15.50 | 26.76 |
| Tangible Book Value Per Share | 0.39 | 0.37 | 0.38 | 0.39 | 0.36 |
| Shareholders’ Equity Per Share | 0.50 | 0.49 | 0.49 | 0.51 | 0.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.32 | 0.49 | 0.04 | 0.23 | -0.29 |
| Revenue Per Share | 0.23 | 0.20 | 0.18 | 0.20 | 0.14 |
| Net Income Per Share | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 |
| Tax Burden | 0.68 | 0.51 | 0.96 | 0.77 | 1.29 |
| Interest Burden | 0.93 | 0.43 | 0.81 | 0.84 | 0.94 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.19 | 0.20 | 0.19 | 0.17 | 0.18 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.48 | 3.18 | 1.33 | 1.97 | 1.11 |
Currency in MYR
